Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). Furthermore, as previously disclosed by the Company, on October 20, 2023, two of UpHealth Holdings’ wholly-owned subsidiaries, Thrasys, Inc. (“Thrasys”) and Behavioral Health Services, LLC (“BHS”), and each of the subsidiaries of Thrasys and BHS (such subsidiaries, collectively with UpHealth Holdings, Thrasys and BHS, being referred to individually herein and collectively as the “Debtors”), filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. The Chapter 11 cases of the Debtors are being jointly administered under the caption In re UpHealth Holdings, Inc., Case No. 23-11476 (U.S. Bankr. D. Del.), for procedural purposes only.
Furthermore, as previously disclosed by the Company in its Current Report on Form 8-K filed with the SEC on May 20, 2024, in furtherance of the anticipated liquidating plan which UpHealth Holdings will seek to confirm in its Chapter 11 case, UpHealth Holdings is moving forward with taking actions with respect to certain assets and rights that it holds, including by continuing to pursue the enforcement of the Award of the ICA to UpHealth Holdings and against the Respondents. In addition to those actions which UpHealth Holdings has taken in India which the Company has previously disclosed, UpHealth Holdings on May 8, 2024 filed a Petition to Confirm Foreign Arbitral Award (the “Petition”) against the Respondents with the U.S. District Court for the Northern District of Illinois (the “Illinois Court”) (Case No. 1:24-cv-3778).
As previously disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, as previously filed with the SEC on June 6, 2024, on May 20, 2024, all Respondents accepted service of the Petition through counsel and agreed on a briefing schedule for the case. On May 22, 2024, the Illinois Court granted the agreed briefing schedule, pursuant to which:
|
(i) |
Respondents will file any opposition to the Petition and/or cross-motion to vacate the Award on or before June 13, 2024; |
|
(ii) |
UpHealth Holdings will file any reply in support of the Petition and/or opposition to any cross-motion to vacate on or before July 3, 2024; and |
|
(iii) |
Respondents will file any reply in support of their cross-motion to vacate on or before July 24, 2024. |
On June 13, 2024, Glocal, the Glocal Board and Kimberlite (collectively, the “Glocal Respondents”) filed with the Illinois Court their Cross-Motion to Vacate Arbitration Award and Opposition to Petition to Confirm Foreign Arbitral Award (the “Glocal Respondents Cross-Motion to Vacate”). On that same day, Damodaran also filed with the Illinois Court a Motion to Vacate and Response to Petition to Confirm Foreign Arbitration Award (the “Damodaran Motion to Vacate” and together with the Glocal Respondents Cross-Motion to Vacate, the “Cross-Motions to Vacate”).
On September 3, 2024, the Illinois Court heard oral arguments with respect to the Petition and the Cross-Motions to Vacate.
On September 24, 2024, the Illinois Court issued its Memorandum Opinion and Order (the “Opinion”) with respect to the Petition and the Cross-Motions to Vacate, and entered judgment (the “Judgment”) on the Petition with respect to the Glocal Respondents. In the Opinion, the Illinois Court denied the Glocal Respondents Cross-Motion to Vacate and granted the Petition with respect to the Glocal Respondents. In so doing, the Illinois Court confirmed the Award as to the Glocal Respondents. The Illinois Court separately denied the Petition with respect to Damodaran, granted the Damodaran Motion to Vacate and vacated the Award as to Damodaran only on the issues identified in the Opinion and remanded to the Tribunal for further proceedings consistent with the Opinion.
The foregoing summaries of the Opinion and Judgment are not complete and are qualified in their entirety by reference to the full text of the Opinion, which is included as Exhibit 99.1, and the Judgment, which is included as Exhibit 99.2, to this Current Report and are incorporated herein by reference.
Forward-Looking Statements
This Current Report contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding applications and motions to the Bankruptcy Court and confirmation of a potential liquidating plan and approval of a related disclosure statement, the enforcement of the Award and the amounts to be paid to UpHealth Holdings by the Respondents pursuant to the Award, and the remand to the Tribunal of the Award with respect to Damodaran. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this Current Report on Form 8-K are based on certain assumptions and analyses made by the management of the Company considering their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company or its subsidiaries, including UpHealth Holdings and TTC